Evidence map›Paper›PMID 32341827›Full record

ArticleTurkish journal of obstetrics and gynecology2020

Evaluation of second-trimester maternal serum betatrophin levels and lipid and carbohydrate metabolism parameters in patients with gestational diabetes mellitus.

Funda Gülcü Bulmuş, Rauf Melekoğlu, Mehmet Ferit Gürsu, Helin Bağcı, Ebru Celik Kavak, Alpaslan Akyol

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. New Insights into Adipokines in Gestational Diabetes Mellitus.International journal of molecular sciences · 2022
    Review
  3. Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Funda Gülcü BulmuşFırat University Faculty of Medicine, Vocational School of Health Services, Elazığ, Turkey.ORCID https://orcid.org/0000-0002-2514-4559
Rauf Melekoğluİnönü University Faculty of Medicine, Department of Obstetrics and Gynecology, Malatya, Turkey.ORCID https://orcid.org/0000-0001-7113-6691
Mehmet Ferit GürsuFırat University Faculty of Medicine, Department of Biochemistry, Elazığ, Turkey.ORCID https://orcid.org/0000-0003-3552-7315
Helin BağcıKarabük University Training and Research Hospital, Clinic of Obstetrics and Gynecology, Karabük, Turkey.ORCID https://orcid.org/0000-0001-9772-3325
Ebru Celik KavakFırat University Faculty of Medicine, Department of Obstetrics and Gynecology, Elazığ, Turkey.ORCID https://orcid.org/0000-0002-7447-8264
Alpaslan AkyolFırat University Faculty of Medicine, Department of Obstetrics and Gynecology, Elazığ, Turkey.ORCID https://orcid.org/0000-0001-5089-8961
Fırat University · TRInonu University · TRKarabük University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe investigated the role of betatrophin in the etiopathogenesis of gestational diabetes mellitus (GDM) and its association with lipid and carbohydrate metabolism in patients with GDM and normoglycemic pregnant women. MATERIALS AND

methodsA total of 60 patients [30 pregnant women with GDM (study group) and 30 healthy age-, body mass index-, and gestational agematched pregnant women (control group)] were included in this study. Serum betatrophin, fasting glucose, insulin, glycated hemoglobin A1c (HbA1c), and C-peptide levels, as well as lipid parameters, were measured.

resultsSerum betatrophin, fasting glucose, HbA1c, insulin, and C-peptide levels were significantly higher in the GDM group than in the control group (p<0.001, p=0.009, p=0.013, p<0.001, and p<0.001, respectively). Levels of triglycerides and very-low-density lipoprotein cholesterol were significantly higher in the GDM group (p=0.020 and p=0.020, respectively), but total cholesterol and LDL cholesterol levels were similar in the two groups (p=0.810 and p=0.273, respectively). Betatrophin levels in the GDM group were correlated positively with insulin levels (r=0.336, p=0.009) and the homeostatic model assessment of insulin resistance (HOMA-IR) score (r=0.269, p=0.038), and negatively with the C-peptide levels (r=-0.399, p=0.002); they were not correlated with any other glucose or lipid parameters. Multivariate stepwise linear regression analysis demonstrated that insulin levels (β=0.134, p=0.013) and the HOMA-IR score (β=0.112, p=0.017) were associated independently with serum betatrophin levels.

conclusionThese results demonstrate that serum betatrophin levels were significantly higher in pregnant women with GDM than in normoglycemic pregnant women. The levels of betatrophin were correlated significantly with insulin resistance parameters, which is a key feature of GDM pathophysiology.

Indexed as

Betatrophingestational diabetes mellitusinsulin resistance

Identifiers

PMID32341827
PMCPMC7171536
OpenAlexW3016145468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.